|
|
|
|
|
Hazardous Drug Compounding Articles |
Title (Click for Abstract / Details) |
Author |
Issue |
Page |
View/Buy |
Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets |
Mulder Kyle
|
Jan/Feb 2020 |
7-12 |
Buy |
Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk |
Cabaleiro Joe
|
Jan/Feb 2020 |
21-27 |
Buy |
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs |
Dillon L R
|
Jan/Feb 2020 |
30-36 |
Buy |
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators |
Mulder Kyle
|
Nov/Dec 2019 |
447-452 |
Buy |
Evaluation of Containment Ventilated Enclosure Performance in Absence of Negative Pressure Containment Secondary Engineering Control |
Hutson Chad, Day A J
|
Nov/Dec 2019 |
511-518 |
Buy |
Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report |
Pope George, Daleo Charles, Batson SL
|
Sep/Oct 2019 |
358-364 |
Buy |
Contamination Control in Compounding Areas |
Mulder Kyle, Gonzales Ben A
|
Jul/Aug 2019 |
271-278 |
Buy |
How to Develop and Maintain a Hazardous Drug List |
Dillon L Rad
|
May/Jun 2019 |
182-186 |
Buy |
Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding? |
Allen Loyd V Jr
|
Mar/Apr 2019 |
123-130 |
Buy |
Certification of Powder-containment Hoods for Nonsterile Compounding |
Mulder Kyle, Dozzi Raphael
|
Sep/Oct 2018 |
369-384 |
Buy |
Compounding Enclosures: Ensuring Safety During the Preparation of Sterile and Nonsterile Formulations |
Ashe Krystina, Baskett Dustin
|
Sep/Oct 2018 |
387-398 |
Buy |
Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags |
Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
|
Jul/Aug 2018 |
345-349 |
Buy |
Trace Level Analysis of Airborne Hormone Particulates |
Trimble John O, Hampton Shanna
|
May/Jun 2018 |
257-263 |
Buy |
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs |
Allen Loyd V Jr
|
Sep/Oct 2017 |
356 |
Buy |
PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives |
Allen Loyd V Jr
|
May/Jun 2017 |
180 |
Buy |
Quality Control: (Material) Safety Data Sheets |
Allen Loyd V Jr
|
Mar/Apr 2017 |
118-124 |
Buy |
Bosentan 6.25-mg/mL Oral Suspension |
Allen Loyd V Jr
|
Nov/Dec 2016 |
505 |
Buy |
Erlotinib 10-mg/mL Oral Suspension |
Allen Loyd V Jr
|
Nov/Dec 2016 |
508 |
Buy |
Imatinib 40-mg/mL Oral Suspension |
Allen Loyd V Jr
|
Nov/Dec 2016 |
510 |
Buy |
PreScription: Patient Access to Pharmaceuticals |
Allen Loyd V Jr
|
May/Jun 2016 |
180 |
Buy |
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal) |
Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
|
Mar/Apr 2016 |
148-154 |
Buy |
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom |
Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura
|
Jul/Aug 2015 |
268-278 |
Buy |
Quality Control Analytical Methods: Establishing Powder-handling Workflow Practices and Standard Operating Procedures: Compounding Pharmacy and Safety |
Prince Bryan, Lundevall Jeremy
|
May/Jun 2014 |
222-226 |
Buy |
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards |
Marks Zach
|
Mar/Apr 2014 |
94-99 |
Buy |
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety |
Prince Bryan, Lundeval Jeremy
|
Nov/Dec 2013 |
485-489 |
Buy |
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists |
Mixon Bill, Nain John
|
May/Jun 2013 |
182-190 |
Buy |
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum |
Zur Eyal
|
Mar/Apr 2012 |
117-124 |
Buy |
Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting |
McElhiney Linda F
|
Jul/Aug 2009 |
300-310 |
Buy |
Compounding for Cancer in Companion Animals |
Mixon William, Northrup Nicole, Vail Jane
|
Jan/Feb 2009 |
42-49 |
Buy |
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs |
Allen Loyd V Jr, Okeke Claudia C
|
Jan/Feb 2009 |
56-62 |
Buy |
Disposing of Expired Drugs and Chemicals: New Options for Compounders |
Vail Jane
|
Jan/Feb 2008 |
38-47 |
View Sample |
PostScription: Consumer Options for Disposal of Unused Medications |
Vail Jane
|
Jan/Feb 2008 |
87 |
Buy |
Basics of Compounding for Hazardous Drugs, Part 4: Developing the Hazardous Drugs List and Containment Workstations |
Allen Loyd V Jr
|
Mar/Apr 2007 |
149-151 |
Buy |
Basics of Compounding for Hazardous Drugs, Part 3: Safe Handling and Personal Protection |
Allen Loyd V Jr
|
Jan/Feb 2007 |
50-51 |
Buy |
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination |
Allen Loyd V Jr
|
Nov/Dec 2006 |
446-448 |
Buy |
Basics of Compounding for Hazardous Drugs, Part 1: An Introduction |
Allen Loyd V Jr
|
Sep/Oct 2006 |
377-379 |
Buy |
Standard Operating Procedure: Labconco Basic 47 Laboratory Hood |
Allen Loyd V Jr
|
Mar/Apr 2006 |
135 |
Buy |
Local Ventilation for Safe Containment in the Pharmaceutical Industry |
Walters Douglas B, Ryan Ray
|
Jul/Aug 2005 |
293-298 |
Buy |
Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products |
Wagner James T
|
Jul/Aug 2005 |
284-290 |
Buy |
Using ACDs in the Practice of Pharmacy |
Kastango Eric S
|
Jan/Feb 2005 |
15-21 |
Buy |
An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices |
Kastango Eric S, Trissel Lawrence A, Bradshaw Brian D
|
Sep/Oct 2003 |
401-416 |
Buy |
Containment of Hazardous Particulates in the Compounding Pharmacy |
Allen Loyd V Jr
|
Jul/Aug 2003 |
281-285 |
Buy |
Product Containment in the Compounding Laboratory |
Vidrine Eric
|
May/Jun 2003 |
213-214 |
Buy |
Facilities and Procedures for Compounding Hazardous Drugs |
Rahe Hank
|
Jul/Aug 2002 |
267-270 |
Buy |
Compounding Containment Devices: Buyer Be Aware |
Kastango Eric S
|
Sep/Oct 2001 |
384-388 |
Buy |
Sterile Compounding with Barrier-Isolation Technology |
Rahe Hank
|
Jul/Aug 2001 |
254-258 |
Buy |
Compounding Using Hazardous Drugs |
Lau Kellie
|
Jul/Aug 2000 |
261-263 |
Buy |